Literature DB >> 9120214

The efficacy of vision therapy for convergence excess.

M Gallaway1, M Schieman.   

Abstract

BACKGROUND: Convergence excess is a commonly encountered non-strabismic ocular motility disorder. There are, however, very few research data that evaluate the effect of vision therapy for this condition in a clinical population.
METHODS: The records of 83 consecutive patients with convergence excess who were treated with vision therapy were reviewed to assess the impact of treatment on clinical findings and patient symptoms.
RESULTS: Statistically and clinically significant changes in direct and indirect measures of negative fusional vergence were seen, with 84% of patients reporting a total elimination of initial symptoms. Larger increases in negative fusional vergence were found than those previously reported. This may be a result of the more extensive and better controlled in-office treatment used in this study.
CONCLUSIONS: Vision therapy was successful in enhancing negative fusional vergence and eliminating symptoms in the vast majority of patients with convergence excess and should be considered an effective treatment for this condition.

Entities:  

Mesh:

Year:  1997        PMID: 9120214

Source DB:  PubMed          Journal:  J Am Optom Assoc        ISSN: 0003-0244


  4 in total

1.  2017 Glenn A. Fry Award Lecture: Establishing an Evidence-based Literature for Vision Therapy - A 25-year Journey.

Authors:  Mitchell M Scheiman
Journal:  Optom Vis Sci       Date:  2018-08       Impact factor: 1.973

Review 2.  Symptomatology associated with accommodative and binocular vision anomalies.

Authors:  Ángel García-Muñoz; Stela Carbonell-Bonete; Pilar Cacho-Martínez
Journal:  J Optom       Date:  2014-07-15

3.  Eye exercises enhance accuracy and letter recognition, but not reaction time, in a modified rapid serial visual presentation task.

Authors:  Paula Di Noto; Sorin Uta; Joseph F X DeSouza
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

4.  Asthenopia in schoolchildren, orthoptic and ophthalmological findings and treatment.

Authors:  Saber Abdi; Agneta Rydberg
Journal:  Doc Ophthalmol       Date:  2006-02-28       Impact factor: 1.854

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.